My Cart
Menu
Back to Home
  • News & Events

News & Events

Stay up to date with the latest product launches, promotions, and technical resources direct to your inbox.

HLAPROTEIN.COM PRESENTS A FREE WEBINAR

Engineering of HLA Peptide Complexes

In this webinar, members of the Pure Protein research team will present and discuss data and learnings drawn from decades of experience working with Human Leukocyte Antigen (HLA) and the company’s proprietary soluble HLA (sHLA) technology.

Presented Wednesday, June 21, 2023. Recording Available.

LEARN MORE

News from Pure Protein

NEWS
Pure Protein L.L.C. Appoints Dr. Rico Buchli as Chief Scientist

OKLAHOMA CITY, OK, Sep. 17, 2024—Pure Protein L.L.C. proudly announces the appointment of Dr. Rico Buchli as Chief Scientist. In his new role, Dr. Buchli will lead scientific initiatives and oversee the expansion of the company’s immunological products and services portfolio.

 September 17, 2024
Pure Transplant Solutions, LLC and Vall d’Hebron University Hospital Announce Research Collaboration – Developing New Technologies & Diagnostic Tools for B-Cell Monitoring in Transplant Rejection

OKLAHOMA CITY, OK, AUSTIN, TX, BARCELONA, SPAIN, February 15, 2022 – Pure Transplant Solutions, LLC (PTS), a collaboration driven biotechnology company focused on the development of human leukocyte antigen (HLA)-based diagnostics and therapeutics within the field of transplantation, is proud to announce that it has entered into a research collaboration with Vall d’Hebron Barcelona Hospital […]

 February 15, 2022
Pure Transplant Solutions, LLC and Oxford Immunotec, Ltd. Announce Exclusive Sublicense Agreement to Support Commercialization of Novel B Cell Measurement Assay for Early Detection of Tissue Injury and Prevention of Organ Rejection

AUSTIN, TEXAS and OXFORD, UNITED KINGDOM, December 7, 2021 — Pure Transplant Solutions, LLC (PTS), a developer of novel HLA based transplant diagnostics, and Oxford Immunotec, Ltd. (OI), a global diagnostics company part of PerkinElmer Inc., today announce an exclusive sublicense agreement in which PTS will obtain exclusive commercial rights to issued patents protecting a novel […]

 December 07, 2021